No. of Recommendations: 2
Xenotherapeutics is an interesting concept to keep an eye on.

First trial of pig skin to human skin transplantation for burn victims. Trial of 6 patients beginning now, estimated completion date July 2019.

https://clinicaltrials.gov/ct2/show/NCT03695939?term=XenoThe...

They're not publicly traded, but this is a relatively quick trial with a clear yes/no answer and ability to get to market fast (for a biotech); plus this would be the clear market leader in transplant technology and they make no bones about wanting to expand to other markets over time:

“Our goal with this initial product is to advance the science of xenotransplantation for practical therapies that can benefit patients around the globe while addressing a critically unmet need for burns; but equally as important, paving the way for future organ transplant solutions,” Holzer said.

https://www.fiercebiotech.com/medtech/fda-clears-first-xenot...

Usually not interested in early stage biotechs, but a company that says: "We are obsessed with solving the HARDEST problems" on their website wins kudos from me.
Print the post Back To Top
No. of Recommendations: 2
I've invested in Vericel (VCEL), a company that already offers FDA approved therapies for cartilage repair and skin grafts using tissue developed from the patient's OWN DNA. It's proven to be a profitable investment for me and the company is still small, but growing.

Here's information on its skin replacement therapy (Epicel):

https://vcel.com/product-portfolio-2/#Epicel
Print the post Back To Top